U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C37H34N6O2
Molecular Weight 594.7049
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CE-326597

SMILES

CC(C)N(CC1=CC=CC=C1)C(=O)CN2C3=CC=CC=C3N4C(=NN=C4C5=CC=CC=C5)[C@H](CC6=CNC7=C6C=CC=C7)C2=O

InChI

InChIKey=UBNMGTSDHSQBEL-PMERELPUSA-N
InChI=1S/C37H34N6O2/c1-25(2)41(23-26-13-5-3-6-14-26)34(44)24-42-32-19-11-12-20-33(32)43-35(27-15-7-4-8-16-27)39-40-36(43)30(37(42)45)21-28-22-38-31-18-10-9-17-29(28)31/h3-20,22,25,30,38H,21,23-24H2,1-2H3/t30-/m0/s1

HIDE SMILES / InChI

Molecular Formula C37H34N6O2
Molecular Weight 594.7049
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

CE-326597 is a potent and selective agonist of type 1 cholecystokinin receptor, developed by Pfizer Inc for the treatment of obesity. The physical properties of CE-326597 provided the desired low systemic exposure which was driven by poor absorption of the drug into the intestinal wall. Unfortunately, CE-326597 demonstrated insufficient efficacy for the treatment of either diabetes or obesity after 12 weeks of dosing in Phase 2 clinical trial and was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity.
2010 Nov 15
Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
2015 Dec 24
Patents

Patents

Sample Use Guides

100 mg QD
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:04:25 GMT 2023
Edited
by admin
on Sat Dec 16 10:04:25 GMT 2023
Record UNII
1FGZ6L9SF2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CE-326597
Common Name English
6H-(1,2,4)TRIAZOLO(4,3-A)(1,5)BENZODIAZEPINE-6-ACETAMIDE, 4,5-DIHYDRO-4-(1H-INDOL-3-YLMETHYL)-N-(1-METHYLETHYL)-5-OXO-1-PHENYL-N-(PHENYLMETHYL)-, (S)-
Systematic Name English
CE-326,597
Code English
6H-(1,2,4)TRIAZOLO(4,3-A)(1,5)BENZODIAZEPINE-6-ACETAMIDE, 4,5-DIHYDRO-4-(1H-INDOL-3-YLMETHYL)-N-(1-METHYLETHYL)-5-OXO-1-PHENYL-N-(PHENYLMETHYL)-, (-)-
Systematic Name English
Code System Code Type Description
PUBCHEM
52949124
Created by admin on Sat Dec 16 10:04:25 GMT 2023 , Edited by admin on Sat Dec 16 10:04:25 GMT 2023
PRIMARY
CAS
870615-40-0
Created by admin on Sat Dec 16 10:04:25 GMT 2023 , Edited by admin on Sat Dec 16 10:04:25 GMT 2023
PRIMARY
DRUG BANK
DB12694
Created by admin on Sat Dec 16 10:04:25 GMT 2023 , Edited by admin on Sat Dec 16 10:04:25 GMT 2023
PRIMARY
FDA UNII
1FGZ6L9SF2
Created by admin on Sat Dec 16 10:04:25 GMT 2023 , Edited by admin on Sat Dec 16 10:04:25 GMT 2023
PRIMARY
SMS_ID
300000041481
Created by admin on Sat Dec 16 10:04:25 GMT 2023 , Edited by admin on Sat Dec 16 10:04:25 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY